Aria Coach

Cancer and tobacco during treatment: impact on efficacy, recurrence and life expectancy

Smoking during cancer treatment multiplies recurrence and weakens radiotherapy. Here is what science says, and how to quit without guilt.

Aria

The scientific basis on quitting smoking was reviewed on a voluntary basis by Pr. Bertrand Dautzenberg , a tobacco specialist, in order to rule out gross, potentially dangerous errors. It reflects positions commonly shared by health professionals and health agencies, without always corresponding exactly to his thinking or his practice. He is not the author of this text; he has only carried out a vigilance review of it.

You have just been diagnosed with cancer. You still smoke. The shame, the fear, the need to breathe make you hit the cigarette harder than before. It is a human reaction, and you are neither weak nor stupid for it.

But there is a truth you are not always told clearly enough: keeping on smoking during your treatment lowers your chances that the treatment will work. And quitting, even late, concretely changes your probability of recovery.

Why tobacco sabotages your treatment

Several documented mechanisms stack up:

  • Hypoxia: carbon monoxide reduces oxygen in your tissues. And radiotherapy needs oxygen to kill tumour cells (the "radiosensitiser" effect).

  • Altered metabolism: smoke modifies certain liver enzymes, which changes how your body handles chemo — often by raising its toxicity.

  • Weakened immunity: fewer natural killer cells in circulation, which are precisely the cells that help clear cancer cells.

  • Chronic inflammation: the inflammatory terrain favours tumour progression and treatment resistance.

× 4.28 the risk of locoregional recurrence in patients who keep smoking during chemoradiotherapy, vs those who quit.

Petros et al., meta-analysis cancer and tobacco, 2022

Radiotherapy: the best-documented scenario

It is on radiotherapy that the evidence is strongest. A recent meta-analysis finds, in active smokers during treatment:

  • +56% risk of locoregional recurrence (radiotherapy alone),

  • × 4.28 risk of recurrence in chemoradiotherapy,

  • +88% risk of poor disease-free survival,

  • +84% risk of severe skin and mucosal toxicity.

For head-and-neck and breast cancers in particular, thresholds have been integrated into clinical protocols: 10 pack-years is a pivotal value in head-and-neck oncology.

Quitting smoking after a cancer diagnosis is one of the most powerful interventions to improve survival, comparable with the best adjuvant treatments.

American Society of Clinical Oncology

Tobacco Cessation Guideline

Chemotherapy: less evidence, but not zero

The effect of tobacco on chemotherapy efficacy is less clear than for radiotherapy — studies are more contradictory. But what is documented:

  • liver toxicity is worse in smokers,

  • post-chemo respiratory complications are more frequent,

  • fatigue and recovery between cycles are harder.

The immunotherapy case: why it is different

For checkpoint inhibitors (anti-PD-1, anti-PD-L1), the literature shows that smokers paradoxically have a better response. Why? Because cancers in smokers often carry more mutations, hence more antigens the immune system can recognise.

And second cancers?

Continuing to smoke after a first cancer multiplies your risk of developing a second — including in locations not commonly associated with tobacco (breast, lymphoma, testicle). Patients treated with radiotherapy for breast cancer who keep smoking see their risk of myocardial infarction multiplied by 3 in the following years.

How to go about it, without guilt

A cancer diagnosis is a period of emotional chaos. The cigarette, in that moment, is not just an addiction — it is also a marker, a lifeline, a familiar ritual in a life that is tipping over.

A few useful principles:

  • Ask for medical help from the start. Many cancer centres have tobacco-cessation consultations. Nicotine substitutes are safe during treatment.

  • Do not set yourself a perfect quit. Cutting in half is already measurable gain.

  • Do not use shame as a driver. It will make you smoke more, not less.

  • Consider vaping. As a transition, it is validated by several professional societies, including in oncology.

In United Kingdom

Your questions

  • If I don’t have a tobacco-related cancer, does it change anything?


    Yes. Even for cancers not linked to tobacco (lymphoma, testicle), tobacco worsens treatment toxicity and raises the risk of a second cancer.
  • My oncologist said nothing. Does that mean there’s no concern?


    Not necessarily — many oncologists are poorly trained in smoking cessation, or don’t dare bring it up for fear of adding pressure. You can ask the question directly.
  • Is it too late if I quit after treatment has started?

    No. Every day less under tobacco is a day of benefit. Studies show a measurable effect even in those who quit during radiotherapy.
  • And vaping — am I allowed during cancer?

    Yes, it is generally compatible and preferable to smoked tobacco. Confirm with your oncologist, especially if you have a head-and-neck or lung cancer.

sources

  • Petros WP et al., Effect of Smoking on Treatment Efficacy and Toxicity in Patients with Cancer: A Systematic Review and Meta-Analysis, Cancers, 2022.

  • Jassem J, Tobacco smoking after diagnosis of cancer: clinical aspects, Translational Lung Cancer Research, 2019.

  • Warren GW et al., Smoking cessation in cancer patients, Surgeon General Report, 2014.

  • ASCO, Tobacco Cessation Guideline for Patients with Cancer, updated 2024.

  • Cancer Research UK, Smoking and cancer treatment, 2024.

related reading